Patient and Graft Survival: Biliary Complications after Liver Transplantation. 2018

Michael Senter-Zapata, and Adeel S Khan, and Tanvi Subramanian, and Neeta Vachharajani, and Leigh Anne Dageforde, and Jason R Wellen, and Surendra Shenoy, and Maria B Majella Doyle, and William C Chapman
Section of Transplant Surgery, Department of Surgery, Washington University School of Medicine, St Louis, MO.

Biliary complications (BCs) affect up to to 34% of liver transplant recipients and are a major source of morbidity and cost. This is a 13-year review of BCs after liver transplantation (LT) at a tertiary care center. We conducted a single-center retrospective review of our prospective database to assess BCs in adult (aged 18 years or older) liver transplant recipients during a 13-year period (2002 to 2014). Biliary complications were divided into 3 subgroups: leak alone (L), stricture alone (S), and both leak and strictures (LS). Controls (no BCs) were used for comparison. There were 1,041 adult LTs performed during the study period; BCs developed in 239 (23%) of these patients: 55 (23%) L, 148 (62%) S, and 36 (15%) LS. One hundred and two (43%) were early (less than 30 d). Surgical revision was required in 42 cases (17%) (30 L, 10 LS, and 2 S), while the remaining 197 (83%) were managed nonsurgically (25 L, 26 LS, and 146 S), with a mean of 4.2 interventions/patient. One-, 3-, and 5-year overall patient and graft survival was significantly reduced in patients with bile leaks (84%, 71%, and 68% and 76%, 67%, and 64%, respectively) compared with controls (90%, 84%, and 78% and 88%, 81%, and 76%, respectively [p < 0.05]). Patients with BCs had higher incidence of cholestatic liver disease, higher pre-LT bilirubin, higher use of T-tubes, higher use of donor after cardiac death grafts, and higher rates of acute rejection (p < 0.05). Patients with BCs had longer ICU and hospital stays and higher rates of 30- and 90-day readmissions (p < 0.01). Multivariate analysis identified cholestatic liver disease, Roux-en-Y anastomosis, donor risk index >2, and T-tubes as independent BC predictors. Biliary complications after LT can significantly decrease patient and graft survival rates. Careful donor and recipient selection and attention to anastomotic technique can reduce BCs and improve outcomes.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D005260 Female Females
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001660 Biliary Tract Diseases Diseases in any part of the BILIARY TRACT including the BILE DUCTS and the GALLBLADDER. Biliary Tract Disease,Disease, Biliary Tract,Diseases, Biliary Tract,Tract Disease, Biliary,Tract Diseases, Biliary
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D015996 Survival Rate The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods. Cumulative Survival Rate,Mean Survival Time,Cumulative Survival Rates,Mean Survival Times,Rate, Cumulative Survival,Rate, Survival,Rates, Cumulative Survival,Rates, Survival,Survival Rate, Cumulative,Survival Rates,Survival Rates, Cumulative,Survival Time, Mean,Survival Times, Mean,Time, Mean Survival,Times, Mean Survival

Related Publications

Michael Senter-Zapata, and Adeel S Khan, and Tanvi Subramanian, and Neeta Vachharajani, and Leigh Anne Dageforde, and Jason R Wellen, and Surendra Shenoy, and Maria B Majella Doyle, and William C Chapman
March 2016, Transplantation proceedings,
Michael Senter-Zapata, and Adeel S Khan, and Tanvi Subramanian, and Neeta Vachharajani, and Leigh Anne Dageforde, and Jason R Wellen, and Surendra Shenoy, and Maria B Majella Doyle, and William C Chapman
September 2013, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society,
Michael Senter-Zapata, and Adeel S Khan, and Tanvi Subramanian, and Neeta Vachharajani, and Leigh Anne Dageforde, and Jason R Wellen, and Surendra Shenoy, and Maria B Majella Doyle, and William C Chapman
June 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
Michael Senter-Zapata, and Adeel S Khan, and Tanvi Subramanian, and Neeta Vachharajani, and Leigh Anne Dageforde, and Jason R Wellen, and Surendra Shenoy, and Maria B Majella Doyle, and William C Chapman
October 2007, Transplantation proceedings,
Michael Senter-Zapata, and Adeel S Khan, and Tanvi Subramanian, and Neeta Vachharajani, and Leigh Anne Dageforde, and Jason R Wellen, and Surendra Shenoy, and Maria B Majella Doyle, and William C Chapman
April 2015, Expert review of gastroenterology & hepatology,
Michael Senter-Zapata, and Adeel S Khan, and Tanvi Subramanian, and Neeta Vachharajani, and Leigh Anne Dageforde, and Jason R Wellen, and Surendra Shenoy, and Maria B Majella Doyle, and William C Chapman
January 2017, Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery,
Michael Senter-Zapata, and Adeel S Khan, and Tanvi Subramanian, and Neeta Vachharajani, and Leigh Anne Dageforde, and Jason R Wellen, and Surendra Shenoy, and Maria B Majella Doyle, and William C Chapman
April 2002, Current treatment options in gastroenterology,
Michael Senter-Zapata, and Adeel S Khan, and Tanvi Subramanian, and Neeta Vachharajani, and Leigh Anne Dageforde, and Jason R Wellen, and Surendra Shenoy, and Maria B Majella Doyle, and William C Chapman
November 2019, Georgian medical news,
Michael Senter-Zapata, and Adeel S Khan, and Tanvi Subramanian, and Neeta Vachharajani, and Leigh Anne Dageforde, and Jason R Wellen, and Surendra Shenoy, and Maria B Majella Doyle, and William C Chapman
January 2006, Clinical transplantation,
Michael Senter-Zapata, and Adeel S Khan, and Tanvi Subramanian, and Neeta Vachharajani, and Leigh Anne Dageforde, and Jason R Wellen, and Surendra Shenoy, and Maria B Majella Doyle, and William C Chapman
January 2008, Khirurgiia,
Copied contents to your clipboard!